Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 151

Results For "RMAT"

1643 News Found

Sun Pharma's Winlevi available in the US
Drug Approval | November 01, 2021

Sun Pharma's Winlevi available in the US

It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years


Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22
News | October 29, 2021

Zydus Wellness PAT at Rs. 21.47 cr. in Q2FY22

Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021


Mandaviya launches the sixth edition of National Formulary of India (NFI)
Public Health | October 29, 2021

Mandaviya launches the sixth edition of National Formulary of India (NFI)

The NFI is published to promote the rational use of medicines in the country.


Finvasia acquires Gini Health as it moves into healthcare tech
Digitisation | October 29, 2021

Finvasia acquires Gini Health as it moves into healthcare tech

Gini Health works in the domain of personalised healthcare


Transforming Healthcare Through AI
Opinion | October 29, 2021

Transforming Healthcare Through AI


AstraZeneca partners with India-Sweden Healthcare Innovation Centre and AIIMS to upskill nurses
Public Health | October 28, 2021

AstraZeneca partners with India-Sweden Healthcare Innovation Centre and AIIMS to upskill nurses

This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one


Sun Pharma introduces treatment for plaque psoriasis in Canada
Drug Approval | October 28, 2021

Sun Pharma introduces treatment for plaque psoriasis in Canada

Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return


Medwiki’s online video library aims to help understand medicines better
Healthcare | October 27, 2021

Medwiki’s online video library aims to help understand medicines better

It answers the most basic questions from a patient’s perspective


U.S. FDA gives green light to Moderna and J&J booster doses
Drug Approval | October 21, 2021

U.S. FDA gives green light to Moderna and J&J booster doses

The authority also allowed mix and match of booster doses once the primary vaccine has been administered.


AstraZeneca India opens clinical data and insights division
News | October 20, 2021

AstraZeneca India opens clinical data and insights division

The division is expected to grow to over a 100-member strong team by 2022